Dr. Gyanika Shukla presented information on COVID-19 vaccines, addressing myths and facts. The document discussed what COVID-19 is, its symptoms, transmission, and treatment. It explained the types of vaccines available in India, including Covishield, Covaxin, and Sputnik V, and addressed common myths regarding vaccine safety, effectiveness, and side effects. The presentation aimed to provide truthful information and clear confusion surrounding COVID-19 vaccination.
Coronaviruses are a group of related viruses that cause diseases in mammals and birds. In humans, coronaviruses cause respiratory tract infections that can be mild, such as some cases of the common cold, and others that can be lethal, such as SARS, MERS, and COVID-19. Symptoms in other species vary: in chickens, they cause an upper respiratory tract disease, while in cows and pigs they cause diarrhea. There are yet to be vaccines or antiviral drugs to prevent or treat human coronavirus infections.
In this presentation, we discuss the clinical trial process for the new Covid-19 vaccines. We discuss the different vaccine types. We also discuss the Covid-19 vaccines that the UK is currently using in the NHS, as well as vaccines likely to be used in the next year.
Coronaviruses are a group of related viruses that cause diseases in mammals and birds. In humans, coronaviruses cause respiratory tract infections that can be mild, such as some cases of the common cold, and others that can be lethal, such as SARS, MERS, and COVID-19. Symptoms in other species vary: in chickens, they cause an upper respiratory tract disease, while in cows and pigs they cause diarrhea. There are yet to be vaccines or antiviral drugs to prevent or treat human coronavirus infections.
In this presentation, we discuss the clinical trial process for the new Covid-19 vaccines. We discuss the different vaccine types. We also discuss the Covid-19 vaccines that the UK is currently using in the NHS, as well as vaccines likely to be used in the next year.
Immunization is single most important step towards control and elimination of infectious disease.
With regards to epidemiology and population demographics, various changes are made from time to time in Immunization Schedule of the National Health Programme.
This slide show encompasses the recent changes made by National Health Commission with regards to Immunization Schedule.
Webinar Series on COVID-19 vaccine: Jointly organized by Malaysian Society of Infection Control and Infectious Diseases (MyICID) & Institute for Clinical Research (ICR), NIH
Speaker: Dr. Low Lee Lee, Infectious Disease Physician at the Hospital Sultanah Bahiyah, Ministry of Health Malaysia.
Coronavirus is the virus which is responsible for causing the disease COVID-19, and it has been declared pandemic by WHO and it is the virus which has been emerged from the bats.
Corona virus disease-2019 (Covid-19 outbreak) epidemiology prevention and con...Arun Singh
This PPT is created and updated on 14 February 2020 and it is about the epidemiology of Corona Virus Disease-19, Its preventive measures were also given, useful for department of Community Medicine
Webinar Series on COVID-19 vaccine: Jointly organized by Malaysian Society of Infection Control and Infectious Diseases (MyICID) & Institute for Clinical Research (ICR), NIH
Speaker: Dr.Benedict Sim Lim Heng is a Consultant Infectious Disease Physician at the Sungai Buloh Hospital, Ministry of Health Malaysia.
The Corona virus pandemic has costed a lot of lives through out the world.
Here are some in formations about what is known so far.
It includes cause, Spread, Signs and Symptoms.
it also has the ongoing myths about corona virus.
This slide presentation historically, statistically and attractively explains various vaccines for covid19 available in India. (Please update the statistical data to current values)
The SARS-Cov2 is highly pathogenic and has spread very rapidly.
Here we have tried to present an overview of the prevailing COVID-19 situation in terms of health impact, pathophysiology, clinical manifestations, diagnosis, management, emergency responses and preparedness.
The research literature is growing rapidly and hopefully it will help in finding an effective vaccine (many in trials) and the best practice for the management and treatment of symptomatic cases.
The health, social and economic impacts would be high by this global killer.
We should be able to learn lessons and hopefully we will be more prepared for any such event in future.
Immunization is single most important step towards control and elimination of infectious disease.
With regards to epidemiology and population demographics, various changes are made from time to time in Immunization Schedule of the National Health Programme.
This slide show encompasses the recent changes made by National Health Commission with regards to Immunization Schedule.
Webinar Series on COVID-19 vaccine: Jointly organized by Malaysian Society of Infection Control and Infectious Diseases (MyICID) & Institute for Clinical Research (ICR), NIH
Speaker: Dr. Low Lee Lee, Infectious Disease Physician at the Hospital Sultanah Bahiyah, Ministry of Health Malaysia.
Coronavirus is the virus which is responsible for causing the disease COVID-19, and it has been declared pandemic by WHO and it is the virus which has been emerged from the bats.
Corona virus disease-2019 (Covid-19 outbreak) epidemiology prevention and con...Arun Singh
This PPT is created and updated on 14 February 2020 and it is about the epidemiology of Corona Virus Disease-19, Its preventive measures were also given, useful for department of Community Medicine
Webinar Series on COVID-19 vaccine: Jointly organized by Malaysian Society of Infection Control and Infectious Diseases (MyICID) & Institute for Clinical Research (ICR), NIH
Speaker: Dr.Benedict Sim Lim Heng is a Consultant Infectious Disease Physician at the Sungai Buloh Hospital, Ministry of Health Malaysia.
The Corona virus pandemic has costed a lot of lives through out the world.
Here are some in formations about what is known so far.
It includes cause, Spread, Signs and Symptoms.
it also has the ongoing myths about corona virus.
This slide presentation historically, statistically and attractively explains various vaccines for covid19 available in India. (Please update the statistical data to current values)
The SARS-Cov2 is highly pathogenic and has spread very rapidly.
Here we have tried to present an overview of the prevailing COVID-19 situation in terms of health impact, pathophysiology, clinical manifestations, diagnosis, management, emergency responses and preparedness.
The research literature is growing rapidly and hopefully it will help in finding an effective vaccine (many in trials) and the best practice for the management and treatment of symptomatic cases.
The health, social and economic impacts would be high by this global killer.
We should be able to learn lessons and hopefully we will be more prepared for any such event in future.
Assessment of awareness, knowledge, readiness, prevalence and determinants o...IvanMorgan2
Assessment of awareness, knowledge, readiness, prevalence and determinants of covid-19 vaccination among adults in mvomero district- Morogoro, Tanzania
The 2019–20 coronavirus pandemic is an ongoing pandemic of coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).[4] The outbreak was first identified in Wuhan, Hubei, China, in December 2019, and was recognized as a pandemic by the World Health Organization (WHO) on 11 March 2020.[5] As of 25 March, more than 422,000 cases of COVID-19 have been reported in more than 190 countries and territories, resulting in more than 18,900 deaths and more than 109,000 recoveries.
COVID-19 (An International Trauma): A Brief Analysis on Research Trends, Impa...AnuragSingh1049
Corona virus disease (COVID-19); have been established as an epidemic of the century. COVID-19, a pandemic is spreading its web throughout the world affecting everyone resulting into mass destruction of populations causing human suffering, creating panic, disturbing everyone economically and stressing all kind of development of entire mankind. COVID-19 is a deadly disease that is supposed to be fatal in 4% of cases. In Severe cases this disease produces enormous respiratory harm like pneumonia, gastrointestinal disorders, weakened immune systems, kidney failure or even death. The pathology of COVID-19 is just similar to SARS and Middle Eastern respiratory syndrome (MERS) corona virus infection. There are no drugs or vaccines for corona viruses yet, including COVID-19. According to WHO Corona virus disease (COVID-19) outbreak situation is persisting with 421,792 confirmed cases and 18,883 confirmed deaths till 23 March 2020. Till now, there are no specific vaccines or treatments for COVID-19. Though, there are multiple of clinical trials, evaluations that may result into potential treatments are ongoing.
Corona viruses are a group of RNA viruses. In late December 2019, Patients with pneumonia with unknown etiology was get admitted in health care facilities in Wuhan, China, and resulted in a pandemic disease which affected more than 200 countries and responsible for 182,989 deaths world wide. The disease is officially named as Coronavirus Disease 2019 COVID 19, by WHO on February 11, 2020 . COVID 19 is a potential zoonotic disease with low to moderate estimated 2 -5 mortality rate. Currently, there is no definite treatment for COVID 19 although some trials are under investigation. Hence, appropriate use of PPE, regular hand hygiene, Respiratory and cough etiquettes, social distancing are some key elements to prevent the spread of disease. Ms. Pabalpreet Kaur | Ms. Eenu | Ms. Pooja Jaswal | Dr. (Mrs.) Jyoti Sarin "The Outbreak of COVID-19: An Overview" Published in International Journal of Trend in Scientific Research and Development (ijtsrd), ISSN: 2456-6470, Volume-4 | Issue-4 , June 2020, URL: https://www.ijtsrd.com/papers/ijtsrd30859.pdf Paper Url :https://www.ijtsrd.com/medicine/nursing/30859/the-outbreak-of-covid19-an-overview/ms-pabalpreet-kaur
INTRODUCTION OF COVID-19, ORIGIN OF COVID-19, STRUCTURE OF COVID-19, CAUSES OF CORON VIRUS, SYMPTOMS OF COVID-19, TYPICAL SYMPTOMS OF COVID-19, MODE OF TRANSMISSION, PEOPLE WHI ARE AT HIGHER RISK, WHY COVID-19 IS SAID T BE AS THE PANDEMIC BY WHO?, PREVENTION, WHAT TO DO, WHAT NOT TO DO, MYTHS AND FACTS OF COVID-19 SPREADING, SOME OTHER CONSEQUENCES OF COVID-19, MOST IMPORTANT POINTS OF COVID-19, COVID-19 VACCINES INTRODUCTION, TYPES OF VACCINES , COVAXIN, COVISHIELD, COVID VACCINE REGISTERATION, WHO CAN REGISTER, WHO SHOULDNT TAKE VACCINE SHOTS, STEP BY STEP GUIDE FOR REGISTERATION, COMPARISON BETWEEN COVAXIN AND COVISHIELD,
Advanced age, having comorbidities, and vitamin D deficiency are three most important reasons for increased vulnerability to COVID-19 and also worsen complications and increase the risk of death. Despite the vast amount of information available and lessons learned, many countries are still not fully utilizing these to manage secondary peaks of COVID-19 infection. Factors associated with worse COVID-19 prognosis include, older age, ethnicity, male sex, having comorbidities, obesity, diabetes, hypertension, and smoking; all these are associate with vitamin D deficiency. COVID-19 symptomatology varies from mostly asymptomatic, to, up to 2% fatality.
Advanced age, having comorbidities, and vitamin D deficiency are three most important reasons for increased vulnerability to COVID-19 and also worsen complications and increase the risk of death.
Despite the vast amount of information available and lessons learned, many countries are still not fully utilizing these to manage secondary peaks of COVID-19 infection. Factors associated with worse COVID-19 prognosis include, older age, ethnicity, male sex, having comorbidities, obesity, diabetes, hypertension, and smoking; all these are associate with vitamin D deficiency. COVID-19 symptomatology varies from
mostly asymptomatic, to, up to 2% fatality. The latter is characterized by cytokine storm, an immune reaction, diffuse arterial thromboembolism, acute respiratory distress syndrome, pulmonary oedema,and death.
COVID 19 is a contagious disease caused by a betacoronavirus, which began in Wuhan, China in late 2019. Until now, this new illness has affected more than 6 million people worldwide, and has claimed more than 300 000 human lives. Governments around the globe were faced with the coronavirus pandemic crisis and designed strategies to slow or halt viral transmission. Measures undertaken included enforcing countrywide lockdowns, banning mass gatherings, closing schools and businesses and halting international travel.
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
The Gram stain is a fundamental technique in microbiology used to classify bacteria based on their cell wall structure. It provides a quick and simple method to distinguish between Gram-positive and Gram-negative bacteria, which have different susceptibilities to antibiotics
Muktapishti is a traditional Ayurvedic preparation made from Shoditha Mukta (Purified Pearl), is believed to help regulate thyroid function and reduce symptoms of hyperthyroidism due to its cooling and balancing properties. Clinical evidence on its efficacy remains limited, necessitating further research to validate its therapeutic benefits.
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Oleg Kshivets
Overall life span (LS) was 1671.7±1721.6 days and cumulative 5YS reached 62.4%, 10 years – 50.4%, 20 years – 44.6%. 94 LCP lived more than 5 years without cancer (LS=2958.6±1723.6 days), 22 – more than 10 years (LS=5571±1841.8 days). 67 LCP died because of LC (LS=471.9±344 days). AT significantly improved 5YS (68% vs. 53.7%) (P=0.028 by log-rank test). Cox modeling displayed that 5YS of LCP significantly depended on: N0-N12, T3-4, blood cell circuit, cell ratio factors (ratio between cancer cells-CC and blood cells subpopulations), LC cell dynamics, recalcification time, heparin tolerance, prothrombin index, protein, AT, procedure type (P=0.000-0.031). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and N0-12 (rank=1), thrombocytes/CC (rank=2), segmented neutrophils/CC (3), eosinophils/CC (4), erythrocytes/CC (5), healthy cells/CC (6), lymphocytes/CC (7), stick neutrophils/CC (8), leucocytes/CC (9), monocytes/CC (10). Correct prediction of 5YS was 100% by neural networks computing (error=0.000; area under ROC curve=1.0).
Basavarajeeyam is an important text for ayurvedic physician belonging to andhra pradehs. It is a popular compendium in various parts of our country as well as in andhra pradesh. The content of the text was presented in sanskrit and telugu language (Bilingual). One of the most famous book in ayurvedic pharmaceutics and therapeutics. This book contains 25 chapters called as prakaranas. Many rasaoushadis were explained, pioneer of dhatu druti, nadi pareeksha, mutra pareeksha etc. Belongs to the period of 15-16 century. New diseases like upadamsha, phiranga rogas are explained.
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
These lecture slides, by Dr Sidra Arshad, offer a quick overview of the physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar lead (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
6. Describe the flow of current around the heart during the cardiac cycle
7. Discuss the placement and polarity of the leads of electrocardiograph
8. Describe the normal electrocardiograms recorded from the limb leads and explain the physiological basis of the different records that are obtained
9. Define mean electrical vector (axis) of the heart and give the normal range
10. Define the mean QRS vector
11. Describe the axes of leads (hexagonal reference system)
12. Comprehend the vectorial analysis of the normal ECG
13. Determine the mean electrical axis of the ventricular QRS and appreciate the mean axis deviation
14. Explain the concepts of current of injury, J point, and their significance
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. Chapter 3, Cardiology Explained, https://www.ncbi.nlm.nih.gov/books/NBK2214/
7. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
Basavarajeeyam is a Sreshta Sangraha grantha (Compiled book ), written by Neelkanta kotturu Basavaraja Virachita. It contains 25 Prakaranas, First 24 Chapters related to Rogas& 25th to Rasadravyas.
1. Dr. Gyanika Shukla,
Project Associate,
DBT, Government of India Funded Project,
Chaudhary Charan Singh University,
Meerut
COVID Vaccination:
Truth and Myth
2. What is COVID-19?
The coronavirus disease 19 (COVID-19) is a highly transmittable and pathogenic viral infection
caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which emerged in
Wuhan, China and spread around the world. It causes acute lung injury (ALI) and acute
respiratory distress syndrome (ARDS) which leads to pulmonary failure and result in fatality.
2
3. 3
Symptoms of COVID-19
Symptoms of COVID-19 disease are dry cough, fever and shortness of breath in the majority of
patients. Patients also experience other signs such as sore throat, headache, myalgia, fatigue and
diarrhea.
4. 4
Genomic
Genomic analysis
revealed that SARS-
CoV-2 is
phylogenetically
related to severe
acute respiratory
syndrome-like
(SARS-like) bat
viruses, therefore
bats could be the
possible primary
reservoir.
5. 5
How it all started?
● The severe acute respiratory syndrome coronavirus
(SARS-CoV), H5N1 influenza A, H1N1 2009 and
Middle East respiratory syndrome coronavirus
(MERS-CoV), all of these are phylogenetically
related to novel corona virus.
● These viruses were thought to infect only animals
until the world witnessed a severe acute respiratory
syndrome (SARS) outbreak caused by SARS-CoV,
2002 in Guangdong, China.
● In 2012, Middle East respiratory syndrome
coronavirus (MERS-CoV) caused an endemic in
Middle Eastern countries.
6. 6
Continued..
At the end of 2019, Wuhan, China experienced an outbreak of a novel coronavirus
that killed more than 1800 and infected over 70000 individuals within 50 days
of the epidemic.
The novel virus was named as Wuhan coronavirus or 2019 novel corona virus
(2019-nCov) by the Chinese researchers. The International Committee on
Taxonomy of Viruses (ICTV) named the virus as SARS-CoV-2 and the disease as
COVID-19.
In 2003, SARS-CoV infected 8098 individuals with mortality rate of 9%, across
26 countries. Novel corona virus (2019) infected 16.6Cr individuals with
mortality rate of 3.7%, across 109 countries (data as retrieved on 22-05-
2021).
14. 14
Transmission of COVID-19
1. Isolation, quarantine
2. Social distancing, use of masks, gloves and
complete PPE (Personal Protective Equipment)
3. Disinfection of frequently touched surfaces,
such as floors, and other commonly used
areas (toilets, washbasins etc.) and objects
(doorknobs, handles, keys etc.)
4. Vaccination
18. 18
Remdesivir (Only
medicine
approved by FDA
for COVID 19
Treatment)
Monoclonal
antibodies are
under study
Older medications
(that are typically
used to treat other
conditions) are also
being tested
Commonly used treatments for COVID-19 and therapies with emergency use
authorizations (EUAs)
FDA approved:
Remdesivir, Dexamethasone, Convalescent plasma, Monoclonal antibodies (bamlanivimab &
REGN-COV2)
NIH recommended:
Hydroxychloroquine, chloroquine, Azithromycin, Tocilizumab, Kinase inhibitors (Baricitinib,
Ruxolitinib, Tofacitinib), Interferons, Kaletra, Ivermectin
19. 19
1. WHOLE VIRUS
2. PROTEIN SUBUNIT
3. VIRAL VECTOR
4. NUCLEIC ACID
(RNA AND DNA)
1. Oral route
2. Subcutaneous route
3. Intramuscular route
4. Intradermal route
5. Intranasal route
1. Covishield (Viral Vector
type)
2. Covaxin (whole virus
type)
3. Sputnik V (Viral vector
type)
Vaccine Types
Vaccination Types
Vaccines being used in India
Vaccines and Vaccination
20. The Serum Institute of India (SII)
makes Covishield.
Bharat Biotech, makes the
locally-developed Covaxin.
The third is Russia's Sputnik V
vaccine.
20
21. 21
India began its vaccination
drive in mid-January and
over 185 million vaccine
doses have been
administered so far.
In early April, daily
vaccinations peaked at 3.6
million but that figure has
since fallen back to around
1.6 million per day.
How fast are people being vaccinated in India?
22. 22
1. Confusion and Lack of
awareness.
2. Technical problems in booking
online slots.
3. Unavailability of vaccine
dosage.
Reasons of slow vaccination drive
24. Truth
Confusion arose when a
false report surfaced on
social media, saying
that the spike protein on
this coronavirus was the
same as another spike
protein called syncitin-1
that is involved in the
growth and attachment
of the placenta during
pregnancy.
The COVID-19 vaccine
will not affect fertility.
Myth
The COVID-19
vaccine can
affect women’s
fertility.
24
25. Truth
Due to the severe health
risks associated with
COVID-19 and the fact that
re-infection with COVID-19
is possible, people may be
advised to get a COVID-19
vaccine even if they have
been sick with COVID-19
before.
People who have gotten sick
with COVID-19 may still
benefit from getting
vaccinated.
Myth
If I’ve already had
COVID-19, I don’t
need a vaccine.
25
26. Truth
China isolated and shared
genetic information about
COVID-19 promptly, so
scientists could start
working on vaccines.
The vaccine developers
didn’t skip any testing steps.
No serious or life-
threatening side
effects have been
reported.
Myth
Researchers
rushed the
development of
the COVID-19
vaccine, so its
effectiveness and
safety cannot be
trusted.
26
27. Truth
The current safety
guidelines have
not changed and
we still require all
individuals to
wear masks inside
all of our
facilities..
Getting the
COVID-19 vaccine
means I can stop
wearing my mask
and taking
coronavirus
precautions.
Myth
27
28. Truth
The vaccine for
COVID-19 cannot
and will not give
you COVID-19.
Getting the
COVID-19
vaccine gives
you COVID-19.
Myth
28
The vaccine helps
your immune system
recognize and fight
the virus does not
cause infection of any
sort.
29. Truth
The RNA from the Viral
vector types of COVID-19
vaccines does enter cells,
but not the nucleus of the
cells where DNA resides.
The mRNA does its job to
cause the cell to make
protein to stimulate the
immune system, and then
it quickly breaks down —
without affecting your
DNA.
Myth
The COVID-19
vaccine enters
your cells and
changes your
DNA.
29
30. Truth
The technology
behind the new
coronavirus
vaccines has been
in development for
almost two
decades.
Myth
The
technology
used to make
the COVID-19
vaccine is
brand new.
30
31. Truth
The COVID-19 vaccines
are authorized by the FDA
and contain normal
vaccine ingredients, such
as fats (which protect the
RNA), salts and sugar.
The COVID-19 vaccines
were not developed using
fetal tissue, and they do
not contain any material,
such as implants,
microchips or tracking
devices.
Myth
The COVID-19
vaccine was
developed
with or
contains
controversial
substances.
31
32. Truth
If there is going
to be a
complication or
side effect (like
an allergic
reaction, for
example) it will
occur within
minutes to
hours of
receiving the
vaccine.
Myth
The
vaccines
can lead to
long-term
side -
effects.
32
33. The vaccine developers of India
have suggested that person with
already compromised immune
system should avoid
vaccination. Like Pregnant
women, person with diabetes,
asthma, pulmonary, liver or
kidney diseases.
3
3
Who should not take the vaccine?
34. 3
4
References
Shereen, M.A., Khan, S., Kazmi, A., Bashir, N.
and Siddique, R., 2020. COVID-19 infection:
Origin, transmission, and characteristics of
human coronaviruses. Journal of advanced
research, 24, pp.91-98.
Hosseini, E.S., Kashani, N.R., Nikzad, H.,
Azadbakht, J., Bafrani, H.H. and Kashani,
H.H., 2020. The novel coronavirus Disease-
2019 (COVID-19): Mechanism of action,
detection and recent therapeutic
strategies. Virology, 551, pp.1-9.
35. 3
5
Here you can talk a bit
about this person
Here you can talk a bit
about this person
Here you can talk a bit
about this person
HELENA JAMES
JENNA DOE
JOHN PATTERSON
Thanks To Coronavirus Warriors